(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/BQeve5fGpq7.png?ph=true&h=300&w=458 "(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | BQeve5fGpq7 |
|---|---|
| InChI | InChI=1S/C17H24FNO2/c1-4-15(20)14-11-17(14,16(21)19(5-2)6-3)12-8-7-9-13(18)10-12/h7-10,14-15,20H,4-6,11H2,1-3H3/t14-,15-,17+/m0/s1 |
| InChIKey | CJFJFHFODDWYKE-YQQAZPJKSA-N |
| Mol Weight | 293.38 g/mol |
| Molecular Formula | C17H24FNO2 |
| Exact Mass | 293.179107 g/mol |
| Enantiomer InChIKey | CJFJFHFODDWYKE-INMHGKMJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(3-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(3-METHYLPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |